Biome Australia Limited
ASX: BIO
Biome delivered record revenue, but limited scale and stretched valuation suggest upside may be constrained without faster execution.
(Source: TradingView) 3-Month Performance Profile of BIO compared to the S&P/ASX 200 (XJO).
Biome posted $8.86 million in revenue for H1 FY25, marking a record half-year, yet the business remains small in scale, raising concerns
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
